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The use of the Gram stain for determination of the presence of bacteria in respiratory secretions is described. Success 
of the procedure depends on the use of fresh samples of high cellular quality. The Gram stain can be used to distinguish 
the presence (among other organisms) of Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis 
enterobacteria and Pseudomonas. This paper also discusses the use of sputum samples for bacteriologic culture and 
the value of bacterial counts in expectorated sputum, and describes the use of transtracheal aspiration and transthoracic 
aspiration puncture. Finally, it considers the optimum procedures for the testing of antibiotic susceptibility of 
presumptive pathogens isolated from the lower respiratory tract. 
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INTRODUCTION 
Infections involving the lower respiratory tract are 
increasingly frequent. A significant part of current 
antibiotic consumption is directed to their control. 
Because of the anatomical vicinity of the subtracheal 
respiratory tree with the highly colonized pharyngeal 
mucosa, most of the bacteria involved in respiratory 
tract infections have their origin in the upper 
respiratory tract, frequently as colonizers. In other 
words, several potential bacterial pathogens belong to, 
or are frequently associated with, upper respiratory tract 
normal microflora. That explains the difficulties in 
establishing an aetiological role for microorganisms 
isolated from samples which are expected to be 
originated in the lower respiratory tract, but which are 
frequently contaminated by bacteria from higher 
anatomical areas [ 11. 
These difficulties emphasize the importance of 
establishing criteria for the microbiological evaluation 
of respiratory specimens. In recent years, new tech- 
nologies have been applied to solve these problems, 
including detection of microbial specific fragments (for 
instance, DNA or R N A  sequences, and protein or 
polysaccharide antigens), or combining these detection 
methods with markers of local inflammatory response. 
In this paper, the simple first-line approach to the 
bacteriologic diagnosis of non-tuberculous respiratory 
tract infection is reviewed. 
THE GRAM STAIN 
The Gram stain of respiratory secretions (most fre- 
quently sputum) remains one of the classical tools for 
the bacteriologic diagnosis of respiratory tract infec- 
tions. For a clinician making a diagnostic and 
therapeutic decision, the accuracy of more sophis- 
ticated methods may well be overtaken by the 
availability, simplicity and rapid response assured by the 
Gram stain. In our Department we have encouraged 
clinicians working at the Infectious Diseases Unit to 
perform Gram-staining themselves, as part of the 
‘clinical’ exploration of the patient suffering from acute 
respiratory tract infection. They have not become 
microbiologists, but many of them are excellent 
‘gramologists’. Most of the positive contributions of the 
Gram stain to the diagnosis depend on the individual 
cumulative experience of relating the microscopic 
images with the clinical peculiarities of the patient and, 
one or two days later, with the bacterial cultures. 
Urgency in making a clinical decision is an important 
contributing factor to the value of a Gram stain. Even 
in the microbiology laboratory, it is advisable to select 
‘vocational gramologists’ (in many cases laboratory 
technicians) for the examination of many respiratory 
samples. 
Most reliable conclusions resulting from the Gram- 
staining are obtained when very fresh samples are 
processed, and the smear is carefully prepared (thin 
films!) with the ‘more representative’ (in general the 
more dense or purulent) portion of the specimen. 
Results are often inconclusive on samples processed 
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with a substantial delay. Cells lose their normal 
morphology, ‘bacteria-like’ forms may appear as a result 
of cell degradation and, above all, non-specific bacterial 
organisms may overgrow in the sample. When the 
smears are prepared in a laboratory near the bedside, 
the clinician may extract useful information from the 
macroscopic examination of the sputum in a Petri dish 
and, at the same time, the obtaining of the best material 
for Gram-stainings is assured. The  bedside inoculation 
of saline-washed (to remove salivary contamination) [2] 
or saline-diluted samples has recently been recognized 
[3] as a very useful strategy to obtain representative 
cultures from the respiratory infection. N o  differences 
are expected to occur for induced sputum samples 
(warm-water aerosol with 10% glycerol and 15% NaC1) 
[4] if compared with spontaneous sputum samples for 
results of Gram stain. 
In essence, the Gram examination of respiratory 
tract specimens is an exercise of morphologic pattern 
recognition; but what should be decided by the 
observer when confronted with a Gram stain? 
Cellular quality of the sample 
Several criteria have become classics in evaluating the 
cellular quality of the sputum [5-81. When these 
criteria are positively fulfilled, the Gram stain may be a 
source of useful information for the clinician; in 
addition, this means that the sample is suitable for 
culture. There are some important exceptions to the 
rule: for instance, if a Legionella pneumophila infection is 
suspected (essentially by the type of patient, rarely by 
the clinical picture), an ‘inconclusive’ Gram stain 
should not discourage the possibilities of culture. Table 
1 shows the widely accepted criteria for evaluating the 
cellular quality of a sputum sample, as used in our 
Hospital. A summary of these criteria frequently used 
Table 1 Classical criteria for evaluation of cellular quality 
of a sputum specimen 
~~~~ ~ ~ 
Quality Epithelial cells’ White cell?” Conclusion 
1 > 25 < 10 Very poor quality. 
2 > 25 18-25 Poor quality. 
3 > 25 > 25 Dubious quality. 
4 18-25 > 25 Sufficient quality. 
5 < 10 > 25 Good quality. 
6 < 25 < 25 Uncertain quality. 
No culture 
No culture 
Culture? 
Culture 
Culture 
No culture 
“per x 100 microscopic field. 
by busy technicians is as follows: the sample has a high 
probability of being representative if it contains > 25 
white cells, and a low probability if < 25 white cells per 
100 x field. The sample is contaminated by non- 
representative material if > 25 squamous cells per 100 
x field are present. In the case of sputum-like material, 
such as endotracheal suction aspirates, the sample is 
considered to be poorly representative of, and not 
useful for, culture in the presence of >10 squamous 
cells per 100 x field [9]. From the point of view of 
microscopy of microbial cells, if more than one 
morphologic type of bacteria is present, even ‘excellent 
quality’ samples may be poorly conclusive to predict the 
cause of respiratory tract infection [lo]. 
Image compatible with Streptococcus pneumoniae 
Gram-positive cocci, of lancet shape, in diplo- or 
short-chains, and sometimes surrounded by clear halos, 
are easily recognised as possible pneuniococci. In 
general a pneumococcal infection is associated with an 
average > 8-10 typical cocci-units per oil-immersion 
field (1,000 X) for 10 fields examined. In Streptococcus 
pneumoniae pneumonia confirmed by invasive tech- 
niques, the above criteria are valid in about 70% of 
cases. Note that a negative result is also important for 
the clinician [l  1,121. 
Image compatible with Haemophilus influenzae 
Gram-negative short bacilli, with some longer cells, are 
compatible with Haemophilus in$uenzae. Unfortunately, 
anaerobes may provide simlar images. The predictive 
value of Gram stain for Haemophilus injuenzae remains 
controversial; a poor predictive value was found by 
some authors [13], in contrast to the good results 
obtained by others [14]. In general, the presence of cells 
compatible with H .  injuenzae, in dense or relatively 
dense quantity (more than 12 per 1000 x), and in 
samples with a poor representation of mixed flora 
(expected to be mainly anaerobic), should support a 
positive diagnosis [ l l ] .  It has been reported that smear 
fixation with methanol enhances the appearance of 
Haemophilus injuenzae in Gram stains [15]. I t  is 
necessary to remember that Haemophilus infiuenzae 
pneumonia is not an unusual complication in patients 
with mechanical ventilation. 
I mag e compatible with Branhamella catarrhalis 
A dense collection of Gram-negative cocci (> 18 per oil 
immersion field) has been suggested as supporting the 
involvement of Branhamella catarrhalis in a lower 
respiratory tract infection [ 1 11. 
2 s 1 2  Cl in ica l  M i c r o b i o l o g y  and In fec t i on ,  Vo lume 1 Supp lemen t  2 
Image compatible with Enterobacteriaceae or 
Pseudomanas 
The presence of Gram-negative bacilli, either short or 
long, with bigger microbial cells than those expected 
for Haemophilus, should be reported. This is particularly 
so in the elderly, in patients with lung cancer and in 
immunodepressed hospitalized patients in general [12]. 
These cells, particularly in the absence of the usual 
Gram-positive flora, could suggest the involvement of 
Enterobacteriaceae or Pseudomonas. The sensitivity and 
specificity of the Gram stain for detecting Klebsiella 
pneumoniae in sputum were 42% and 69% respectively 
in a recent study [16]. Nevertheless, it is important to 
note that the possibility of detecting enterobacteria-like 
images, without any clinical implication, is particularly 
high among patients undergoing Hz-blocker treatment 
[17], or if the delay in processing the sputum for Gram 
stain has been more than 2 to 3 hours. 
Additional images 
The presence of intracellular organisms in polymor- 
phonuclear cells and macrophages may be indicative of 
the involvement of these bacteria in the infective 
process, but the threshold for the evaluation remains 
very controversial [18]. The Gram stain may also reveal 
unexpected clues useful for the bacteriologic diagnosis 
of respiratory tract infections. A good example is the 
morphologic suspicion of the presence of Mycobacterium 
tuberculosis infection, when ‘negative’ images (non- 
Gram-stained) of long or side-by-side attached bacilli 
are detected, and further confirmed by specific staining 
procedures. 
The Gram stain in cystic fibrosis should be treated 
as a special case. The sputum in cystic fibrosis reflects 
very accurately the bronchial content. The frequent 
high cellular and bacterial density at  the bronchial level 
overcomes any possible significant contamination of the 
oropharyngeal flora. In a recent study in the Unit for 
Cystic Fibrosis at  our Hospital, the number of white 
(PMN) cells was > 104/mL and the number of epithelial 
cells was only 102/mL, coincident with high bacterial 
counts (> 105/mL). Conversely, in samples with low 
bacterial counts (< lo5), the number of white cells was 
only 102/mL and epithelial cells accounted for 103/mL. 
These data document the relationship of the presumed 
active bacterial infection and the type of cells which can 
be differentiated by Gram-staining. Nevertheless, the 
only Gram stain of interest in adult cystic fibrosis 
patients is for the evaluation of the presence or relative 
predominance of bacterial cells compatible with 
Staphylococcus aweus, eventually to supplement the anti- 
Pseudomonas therapy. 
Sputum 
The sceptical attitude on the value of routine sputum 
culture was inaugurated in 1971 by Barret-Conner 
[19]. An extreme position, which is still maintained in 
many hospitals, is that all sputum samples should be 
rejected for conventional bacteriologic culture. This 
decision is taken for the following reasons: 
1. Most respiratory tract pathogens-such as 
Streptococcus pneumoniae or Haemophilus injuenzae-can 
be found as part of the normal human flora of the 
nasopharynx or pharyngeal mucosa, and therefore 
isolation in sputum does not represent any proof of its 
involvement in a lower respiratory tract infection. 
2. The yield of Streptococcus pneumoniae in sputum 
is only 50% in patients with pneumococcal pneumonia 
3. Many organisms with irregular involvement in 
respiratory tract infections, such as Staphylococcus aureus, 
Enterobacteriaceae or Pseudomonas, can often be found in 
sputum samples. This results from the frequent 
upper respiratory tract colonization in elderly or 
hospitalized patients, particularly if they have had 
prolonged or repeated prior antibiotic treatment, or if 
the sputum sample has not been immediately pro- 
cessed. 
4. The non-critical overestimation of the micro- 
biological results by the clinician may be followed by 
selection of inappropriate (and frequently expensive) 
antibiotic therapy, directed to cover false microbial 
targets. Conversely, empiric (blind) antibiotic therapy of 
respiratory tract infections often provides equal or even 
better results than microbiologically-guided therapy. 
Several different circumstances should be distin- 
guished: 
(1) In a non-immunocompromised patient with- 
out relevant underlying disease, suffering from an acute 
lower respiratory tract infection without particular signs 
of clinical severity, pathogens such as Streptococcus 
pneurnoniae, H. infuenzae, Mycoplasma pneumoniae, 
Coxiella or Chlamydia infection, can be suspected. The 
usefulness of sputum conventional culture as a better 
guide than Gram stain for early antibiotic selection is 
doubtful. Positive cultures for Streptococcus pneumoniae 
or H .  infuenzae without a relevant Gram stain may be 
misleading at the time of selecting a treatment. 
Conversely, negative cultures for Streptococcus pneu- 
rnoniae or H .  inzuenzae may help to exclude these 
pathogens. Moreover, in case of failure, sputum culture 
may provide some clues for selection of alternative 
antibiotic therapy. 
2. The patient suffering from an acute exacer- 
bation of a chronic bronchitis. If the severity markers 
~ 9 1 .  
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(for instance, cardiovascular disease or very frequent 
exacerbations during the preceding months) provide a 
possible indication for antibiotic therapy, the sputum 
culture is rarely of value in determining the etiology 
and the early drug selection. Most of these patients have 
chronic colonization with different potential patho- 
gens. Nevertheless, sputum culture may be useful in 
determining the resistance pattern of the colonizing- 
infecting organisms, and to consider these data for later 
treatments. 
3. The patient may suffer from chronic bacterial 
lung infection, as in the case in cystic fibrosis. In this 
particular case, sputum provides a reliable sample for 
the evaluation of the colonizing-infecting organism, 
and may be useful as a guide to therapy. 
4. An immunocompromised or elderly patient 
may have a serious lung infection. In this case 
hospitalization and more invasive techniques are fre- 
quently recommended; culture of the sputum may 
be considered only if these techniques are not avail- 
able. Samples should be obtained as early as possible, 
and bacterial counts may provide better certainty in 
etiologic attribution. 
Serial dilution and calibrated loop methods for 
quantitative respiratory secretion culture have been 
extensively used, particularly in ventilator-associated 
pneumonia [20,21]. The same approach could be 
applied to sputum samples. Prior to performing 
dilution plating, mucopurulent samples should be 
digested using an equal volume of a mucolytic agent 
such as N-acetyl-cysteine or dithiothreitol, and then 
vigourously vortexed to ensure regular distribution of 
organisms. Ten-fold or hundred-fold serial dilutions are 
carried out in saline. Bacterial counts are obtained by 
planting measured volumes, 0.01 or O.lniL, on agar 
plates. Counts are made from the dilution showing the 
greatest number of colonies without confluence or 
over-crowding, generally up to several hundred. The 
calibrated loop method is similar to that employed for 
quantitative urine cultures. 
Nevertheless, the usefulness of bacterial counts in 
expectorated sputum is a controversial issue [2,6,22]. In 
acute infections, such as pneumonia, bacterial counts in 
sputum or tracheal aspirates have a low specificity in 
determining the bacterial etiology of the infection, and 
therefore quantitative or semi-quantitative techniques 
are rarely used, except in some clinical trials. In some 
of these studies, bacterial counts of a recognized 
respiratory pathogen in counts superior to > lo5 to lo6 
bacteria/mL may be indicative of its involvement in 
the process, but results are very frequently misleading 
and should always be taken with extreme caution. 
In chronic bacterial infections such as cystic fibrosis, 
bacterial counts of Pseudomonas aeruginosa (> 1Oh/mL) 
have in our Unit, shown a good correlation with lung 
damage (Tiffenau indexes < 50), and this quantitative 
limit (or > 1OS/niL in the case of Staphylococcus auyeus) 
serves as a guide for antibiotic prescription [23J. 
High total bacterial counts generally correlate with 
the presence of more PMNs in the sputum sample 
[4,5]. Interestingly, some correlation of high total 
bacterial counts and the degree of inflammatory 
response has also been shown in chronic bronchitis 
[24]. For this type of quantitative study, the pharyngeal 
colonization is not a major problem, as a significantly 
greater polybacterial colonization of the oropharynx 
has been reported in chronic bronchitis patients, perhaps 
as a result of an increase in bacterial adherence [25]. 
The type of bacteria present is probably of only of 
partial relevance, and isolation of Streptococcus (of the 
viridum group, Haerizophilur para-injuenzue, entero- 
bacterial or Pseudomonas strains, should be taken into 
account. A total number >los to 106 bacteria/mL 
tends to suggest abnormal, excessive growth. 
Obviously, bronchial infection in cystic fibrosis and 
in chronic obstructive pulmonary disease have many 
features in common. In both cases, antibiotic therapy 
may be useful, despite the lack of an apparent bacterio- 
logical target or microbiological success. This strongly 
suggests that both processes could be considered as 
bacterial overgrowth syndromes, where the quantity of 
organisms, more than their specific pathogenic potential, 
provides a non-specific but significant release of oligo- 
saccharides or cell wall fragments able to trigger the 
local host inflammatory response [26]. In these cases, 
the beneficial effect of antibiotics is essentially the 
reduction in the total bacterial numbers. 
In obstructive pneumonia associated with lung 
cancer, counts of > lo7 bacteria/mL in the sputum or 
104/mL in the bronchial aspirate may be considered as 
a marker of significant etiology, even for Entero- 
bacteriaceae. 
Deep samples 
In acute lower respiratory tract infections of the 
inimunocompromised host, in ventilator-associated 
infections, and even in severe pneumonic disease in 
non-ventilated patients, the bacteriologic diagnosis 
based on bronchoscopic samples is frequently indicated. 
These samples are obtained by bronchial washes or 
brushes, by protected specimen brushing, by broncho- 
alveolar lavage or by transbronchial biopsy. Trans- 
tracheal aspiration results depend greatly on the 
experience of- the group performing the technique. In 
a series carried out in our Hospital (E. Bouza, personal 
communication), specificity rates were higher than 
95%. Excellent results have also been obtained by the 
use of ultrafine needle transthoracic aspiration function, 
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where the sensitivity and specificity rates may exceed 
50% and 96% respectively [27]. Interestingly, these 
techniques are not only useful as a source of a good 
specimen for culture, but also for antigen detection. 
Bacterial counts in these samples give reliable 
information on the etiology of lower respiratory tract 
infections. In practice, the limits for positive evaluation 
ofdeep samples are lo2 to lo3 bacteria/mL in protected 
brush specimens, transbronchial biopsies and 
transthoracic aspirations, and lo4 to lo5 bacteria/niL in 
bronchoalveolar lavage material and bronchial washes 
or brushes [20]. Nevetheless, it is advisable that these 
quantitative results be interpreted with caution 
considering the important intra-individual variability, 
as has been shown in some cases [28]. 
The bacteriologic study by culture of severe 
respiratory tract infections should necessarily consider 
culture of blood specimens, and pleural fluid if 
present. 
Special cultures 
The routine cultivation of respiratory samples for 
microorganisms whose isolation requires particular (and 
generally more expensive) technology, is rarely of 
interest for the selection of therapy in the individual 
patient with a lower respiratory tract infection. Never- 
theless, the use of cultures is extremely important in 
following the epidemiologic trends of respiratory 
disease, and eventually to maintain surveillance of the 
appearance of new mechanisms of resistance. 
Chlamydia pneumoniae isolation is frequently 
disappointing, and that may reflect large differences in 
prevalence among different geographical areas. The 
inoculation of bronchoalveolar lavages on cyclo- 
heximide-treated Hep-2 or NCI-H292 cells, 
particularly after continuous propagation in four 
culture passages, appears to give the best results [29], 
but positive cultures may occur in fully asymptomatic 
patients [30]. Similar difficulties in obtaining positive 
cultures occur in some areas of the world for Legionella 
pneumophila, despite the use of selective media. The 
efficacy of diagnostic-based immunofluorescence and 
particularly on urinary antigen detection, has dimin- 
ished the interest of clinical laboratories in maintaining 
the efforts destined to cultivate the pathogen. 
Mycoplasma pneumoniae isolation in sputum is a 
useful technique to document its involvement in lower 
respiratory tract infection; nevertheless, bacterial 
growth requires a prolonged period of incubation and 
may be negative even in the presence of the infection 
(sensitivity 20-64%, see the paper by Mauch in this 
issue). If sputum is not available, pharyngeal exudate 
may be cultured [31]. The presence of Mycoplasma 
pneumoniae in the pharynx is exceptional in patients 
without infection, except in close relatives of the 
patient. Pharyngeal culture also enables a retrospective 
diagnosis of Mycoplasma infection to be made, even 
when the clinical process is apparently cured. 
ANTIBIOTIC SUSCEPTIBILITY TESTING 
In the case of Streptococcus pneumoniae, it is important to 
ascertain whether the strain has diminished 
susceptibility (MIC 20.125 pg/mL but I1 pg/mL) or 
high-level resistance (> 1 pg/mL) to penicillin, In 
general, this result applies for the evaluation of all p- 
lactam antibiotics. In respiratory tract infections, most 
strains with diminished susceptibility to penicillin may 
remain treatable with oral agents such as amoxycillin, 
and cefuroxime or cefpodoxime, but rarely with other 
oral cephalosporins. Moreover, strains with 2 pg/mL, 
may still respond to high dosages of these p- 
lactams, but in the case of severe infection parenteral 
administration is required. In many countries, 
penicillin-resistant pneumococci should be considered 
resistant also to trimethoprim-sulphmethoxazole. MIC 
testing is advisable for such evaluation, and simple 
techniques such as a single penicillin E-test are of 
importance as a guide to therapy. In the case of 
macrolides, a simple disk test with erythromycin may 
provide key information about the possibilities of using 
this type of drug. The selection of one or the other 
should be based on the pharmacokinetic properties 
leading to easier administration or reduced side effects. 
In general, overdosage does not help to control a 
macrolide-resistant strain. The in vitro results with 
fluoroquinolones can be misleading on occasions 
because of the appearance of some failures in strains 
with only small increases in MIC. 
In H. injuenzae, the laboratory identification of a 
p-lactamase producer strain is important, not only 
because amino-penicillins will be unable to control the 
infection (not the case with amoxycillin-clavulanate), 
but also because p-lactamase production may also 
inactivate some oral cephalosporins (such as cefaclor), 
despite apparent susceptibility in the test tube. 
Macrolides should not be primarily tested against H. 
infEuenzae. Some macrolides may be useful in infections 
involving Haemophilus, but in vitro testing gives 
extremely variable results in the same strain (i.e. one 
day susceptible and the following day resistant, or vice 
versa). Fluoroquinolones are almost always active, but 
some resistant strains appear during treatment of 
chronic bronchial infections, and surveillance is 
required. 
With Branhamella catarrhalis the laboratory 
detection of p-lactamase production is essential. As in 
the case of Haemophilus, many oral cephalosporins may 
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fail in P-lactamase-producing strains. It is to be 
remembered that the BRO-1 P-lactamase from €3. 
catarvhalis has cephalosporinase activity 1321. At the 
present time, Branhamella remains entirely susceptible to 
macrolides, and susceptibility testing is not required. 
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